a formulation of 3.0 g of ticarcillin and 0.1 g of clavulanic acid was evaluated in the treatment of skin and soft tissue infections , and its efficacy was compared with that of moxalactam in a randomized open study .
C0040193
ticarcillin
C0149778
soft tissue infections